Literature DB >> 22051807

Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging.

Y Wang1, S R Butros, X Shuai, Y Dai, C Chen, M Liu, E M Haacke, J Hu, H Xu.   

Abstract

BACKGROUND AND
PURPOSE: MSA-P and IPD have similar clinical presentations that may complicate accurate clinical diagnosis. Different iron-deposition patterns of those 2 diseases have been demonstrated in histopathology. The aim was to demonstrate the different iron-deposition patterns of MSA-P and IPD by using SWI phase images.
MATERIALS AND METHODS: Sixteen patients with IPD, 8 with MSA-P, and 44 age-matched healthy controls underwent SWI of brain. The different phase shifts as well as the high iron percentage of the area in several gray nuclei were statistically evaluated. The putamen was divided into 4 subregions for further analysis.
RESULTS: Patients with MSA-P had significantly higher iron deposition in the putamen and PT compared with those with IPD (P < .05). Moreover, ROC curves indicated slightly more sensitivity in differentiating MSA-P from IPD, by means of the high-iron-deposition-percentage area than the average phase shift (putamen: AUC = 0.88 versus 0.78; PT: AUC = 0.79 versus 0.62). Moreover, the lower inner region of the putamen was the most valuable subregion in differentiating MSA-P from IPD among the 4 subregions (AUC = 0.92 and 0.91 for high-iron-percentage area and average phase shift, respectively).
CONCLUSIONS: Higher iron deposition in the putamen and PT may differentiate MSA-P from IPD, but the lower inner region of the putamen may be better compared with the PT and other subregions of the putamen. Moreover, the high iron percentage makes it possible to detect smaller increases in iron content more confidently in comparison with average phase shift.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22051807      PMCID: PMC7964805          DOI: 10.3174/ajnr.A2765

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  49 in total

1.  T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content.

Authors:  J Vymazal; A Righini; R A Brooks; M Canesi; C Mariani; M Leonardi; G Pezzoli
Journal:  Radiology       Date:  1999-05       Impact factor: 11.105

Review 2.  Iron metabolism in Parkinsonian syndromes.

Authors:  Daniela Berg; Helmine Hochstrasser
Journal:  Mov Disord       Date:  2006-09       Impact factor: 10.338

3.  MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content.

Authors:  N Gelman; J M Gorell; P B Barker; R M Savage; E M Spickler; J P Windham; R A Knight
Journal:  Radiology       Date:  1999-03       Impact factor: 11.105

4.  Brain ferritin iron may influence age- and gender-related risks of neurodegeneration.

Authors:  George Bartzokis; Todd A Tishler; Po H Lu; Pablo Villablanca; Lori L Altshuler; Michele Carter; Danny Huang; Nancy Edwards; Jim Mintz
Journal:  Neurobiol Aging       Date:  2006-03-24       Impact factor: 4.673

5.  Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.

Authors:  F Yekhlef; G Ballan; F Macia; O Delmer; C Sourgen; F Tison
Journal:  J Neural Transm (Vienna)       Date:  2003-02       Impact factor: 3.575

6.  Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography.

Authors:  E van Royen; N F Verhoeff; J D Speelman; E C Wolters; M A Kuiper; A G Janssen
Journal:  Arch Neurol       Date:  1993-05

7.  Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases.

Authors:  E G Spokes; R Bannister; D R Oppenheimer
Journal:  J Neurol Sci       Date:  1979-09       Impact factor: 3.181

8.  T2*-weighted MRI in diagnosis of multiple system atrophy. A practical approach for clinicians.

Authors:  Friederike von Lewinski; Carola Werner; Torsten Jörn; Alexander Mohr; Friederike Sixel-Döring; Claudia Trenkwalder
Journal:  J Neurol       Date:  2007-03-14       Impact factor: 4.849

9.  Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging.

Authors:  E Mark Haacke; Malek Makki; Yulin Ge; Megha Maheshwari; Vivek Sehgal; Jiani Hu; Madeswaran Selvan; Zhen Wu; Zahid Latif; Yang Xuan; Omar Khan; James Garbern; Robert I Grossman
Journal:  J Magn Reson Imaging       Date:  2009-03       Impact factor: 4.813

10.  MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease.

Authors:  Paraskevi Kosta; Maria I Argyropoulou; Sofia Markoula; Spyridon Konitsiotis
Journal:  J Neurol       Date:  2005-06-29       Impact factor: 6.682

View more
  54 in total

1.  Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism.

Authors:  Keita Kuya; Yuki Shinohara; Fuminori Miyoshi; Shinya Fujii; Yoshio Tanabe; Toshihide Ogawa
Journal:  Neuroradiology       Date:  2016-01-16       Impact factor: 2.804

2.  Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.

Authors:  Niels Bergsland; Eleonora Tavazzi; Ferdinand Schweser; Dejan Jakimovski; Jesper Hagemeier; Michael G Dwyer; Robert Zivadinov
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

Review 3.  Diagnosis and differential diagnosis of MSA: boundary issues.

Authors:  Han-Joon Kim; Beom S Jeon; Kurt A Jellinger
Journal:  J Neurol       Date:  2015-02-07       Impact factor: 4.849

Review 4.  Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.

Authors:  Adriane Gröger; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2012-08-09       Impact factor: 3.575

5.  Genetics of Parkinson disease.

Authors:  E Ben-David; R Tu
Journal:  AJNR Am J Neuroradiol       Date:  2014-09-04       Impact factor: 3.825

Review 6.  Review: Novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathy.

Authors:  E Valera; G Monzio Compagnoni; E Masliah
Journal:  Neuropathol Appl Neurobiol       Date:  2016-02       Impact factor: 8.090

Review 7.  Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.

Authors:  Xiaojun Guan; Xiaojun Xu; Minming Zhang
Journal:  Neurosci Bull       Date:  2017-05-17       Impact factor: 5.203

8.  Effects of Age, Gender and Hemispheric Location on T2 Hypointensity in the Pulvinar at 3T.

Authors:  Matthew L White; Yan Zhang; Jason T Helvey; Fang Yu; Matthew F Omojola
Journal:  Neuroradiol J       Date:  2014-12-01

Review 9.  The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes.

Authors:  Florian Holtbernd; David Eidelberg
Journal:  Semin Neurol       Date:  2014-06-25       Impact factor: 3.420

10.  Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy.

Authors:  Jae-Hyeok Lee; Yong-Hee Han; Bok-Man Kang; Chi-Woong Mun; Sang-Jae Lee; Seung-Kug Baik
Journal:  J Neurol       Date:  2013-05-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.